Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunogenic Cell Death and Immunomodulatory Effects of Cabozantinib.
Scirocchi F, Napoletano C, Pace A, Rahimi Koshkaki H, Di Filippo A, Zizzari IG, Nuti M, Rughetti A. Scirocchi F, et al. Among authors: rughetti a. Front Oncol. 2021 Oct 20;11:755433. doi: 10.3389/fonc.2021.755433. eCollection 2021. Front Oncol. 2021. PMID: 34745989 Free PMC article.
MGL Receptor and Immunity: When the Ligand Can Make the Difference.
Zizzari IG, Napoletano C, Battisti F, Rahimi H, Caponnetto S, Pierelli L, Nuti M, Rughetti A. Zizzari IG, et al. Among authors: rughetti a. J Immunol Res. 2015;2015:450695. doi: 10.1155/2015/450695. Epub 2015 Dec 29. J Immunol Res. 2015. PMID: 26839900 Free PMC article. Review.
Exploratory Pilot Study of Circulating Biomarkers in Metastatic Renal Cell Carcinoma.
Zizzari IG, Napoletano C, Di Filippo A, Botticelli A, Gelibter A, Calabrò F, Rossi E, Schinzari G, Urbano F, Pomati G, Scagnoli S, Rughetti A, Caponnetto S, Marchetti P, Nuti M. Zizzari IG, et al. Among authors: rughetti a. Cancers (Basel). 2020 Sep 14;12(9):2620. doi: 10.3390/cancers12092620. Cancers (Basel). 2020. PMID: 32937860 Free PMC article.
Immunogenicity of allo-vesicle carrying ERBB2 tumor antigen for dendritic cell-based anti-tumor immunotherapy.
Napoletano C, Rughetti A, Landi R, Pinto D, Bellati F, Rahimi H, Spinelli GP, Pauselli S, Sale P, Dolo V, De Lorenzo F, Tomao F, Benedetti-Panici P, Frati L, Nuti M. Napoletano C, et al. Among authors: rughetti a. Int J Immunopathol Pharmacol. 2009 Jul-Sep;22(3):647-58. doi: 10.1177/039463200902200310. Int J Immunopathol Pharmacol. 2009. PMID: 19822081 Free article.
87 results